PortfoliosLab logoPortfoliosLab logo
IPO Date
Nov 19, 2014

Highlights

Market Cap
$91.83M
Enterprise Value
$92.14M
EPS (TTM)
-$0.41
Gross Profit (TTM)
-$220.00K
EBITDA (TTM)
-$27.38M
Year Range
$0.92 - $1.92
ROA (TTM)
-63.96%
ROE (TTM)
-141.93%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Vivani Medical Inc.

Performance

VANI Performance Chart

Vivani Medical Inc. (VANI) is down 8.1% since the beginning of the year. At $1 per share, VANI is trading 41.1% below its 52-week high of $2. Investors who bought $1,000 worth of VANI shares 5 years ago would now be looking at an investment worth $73.


Loading charts...

S&P 500 Index

Returns By Period

Vivani Medical Inc. (VANI) has returned -8.13% so far this year and -10.32% over the past 12 months. Over the last ten years, VANI has returned -35.12% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.


Vivani Medical Inc.

1D
-1.74%
1M
-5.83%
YTD
-8.13%
6M
-21.53%
1Y
-10.32%
3Y*
-3.56%
5Y*
-40.73%
10Y*
-35.12%

Benchmark (S&P 500 Index)

1D
-0.37%
1M
-0.01%
YTD
9.16%
6M
8.64%
1Y
25.22%
3Y*
19.78%
5Y*
11.99%
10Y*
13.88%
*Multi-year figures are annualized to reflect compound growth (CAGR)

VANI Monthly Returns History

Based on dividend-adjusted daily data since Nov 19, 2014, VANI's average daily return is +0.08%, while the average monthly return is +1.35%. At this rate, an investment would double in approximately 4.3 years.

Historically, 39% of months were positive and 61% were negative. The best month was Mar 2021 with a return of +374.1%, while the worst month was Mar 2020 at -76.9%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 7 months.

On a daily basis, VANI closed higher 41% of trading days. The best single day was Mar 5, 2021 with a return of +304.9%, while the worst single day was Mar 30, 2020 at -51.3%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202613.01%-11.51%-18.70%34.00%-1.49%-14.39%-8.13%
20252.59%-6.72%-5.41%-1.90%22.33%2.38%3.88%-14.18%22.61%14.18%-15.53%-9.56%6.03%
2024-0.98%317.82%-56.16%-12.43%0.62%-22.70%-2.38%6.50%-10.69%11.97%9.92%-19.44%13.73%
202341.23%-8.33%-9.09%11.00%18.02%-7.63%4.13%-26.58%10.26%1.96%-8.65%7.37%20.04%
2022-14.11%-6.43%9.16%3.50%58.78%-13.62%-11.33%-23.33%-44.93%-20.61%-22.65%-39.31%-82.62%
202115.51%-19.44%374.14%-16.48%-13.21%-17.39%-22.67%1.05%-17.36%-14.11%-27.74%-17.68%-12.83%

Benchmark Metrics

Vivani Medical Inc. has an annualized alpha of 7.43%, beta of 1.00, and R2 of 0.01 versus S&P 500 Index. Calculated based on daily prices since November 19, 2014.

  • This stock participated in 245.44% of S&P 500 Index downside but only 75.70% of its upside - more exposed to losses than it benefited from rallies.
  • R2 of 0.01 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
7.43%
Beta
1.00
0.01
Upside Capture
75.70%
Downside Capture
245.44%

Return for Risk

Risk / Return Rank

VANI ranks 37 for risk / return — below 37% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.


VANI Risk / Return Rank: 3737
Overall Rank
VANI Sharpe Ratio Rank: 3636
Sharpe Ratio Rank
VANI Sortino Ratio Rank: 3939
Sortino Ratio Rank
VANI Omega Ratio Rank: 3838
Omega Ratio Rank
VANI Calmar Ratio Rank: 3636
Calmar Ratio Rank
VANI Martin Ratio Rank: 3636
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Vivani Medical Inc. (VANI) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


VANIBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

-2.18

Sortino ratioReturn per unit of downside risk

-2.45

Omega ratioGain probability vs. loss probability

1.03

1.37

-0.33

Calmar ratioReturn relative to maximum drawdown

-0.21

2.78

-2.99

Martin ratioReturn relative to average drawdown

-0.38

12.44

-12.82

Dividends

Dividend History


Vivani Medical Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Vivani Medical Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Vivani Medical Inc. was 99.85%, occurring on Dec 30, 2022. The portfolio has not yet recovered.

The current Vivani Medical Inc. drawdown is 99.80%.


Related event

Drawdown

Fall

Recovery

Underwater

Bear market2022
-99.85%Dec 2022
8y 1mo
11y 7moNov 2014 - now

Drawdown Indicators


VANIBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-99.85%

-56.78%

-43.07%

Max Drawdown (1Y)

Largest decline over 1 year

-49.84%

-9.10%

-40.74%

Max Drawdown (3Y)

Largest decline over 3 years

-77.77%

-18.90%

-58.87%

Max Drawdown (5Y)

Largest decline over 5 years

-94.62%

-25.43%

-69.19%

Max Drawdown (10Y)

Largest decline over 10 years

-99.16%

-33.92%

-65.24%

Current Drawdown

Current decline from peak

-99.80%

-1.80%

-98.00%

Average Drawdown

Average peak-to-trough decline

-92.28%

-10.71%

-81.57%

Ulcer Index

Depth and duration of drawdowns from previous peaks

27.47%

2.03%

+25.44%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Vivani Medical Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Vivani Medical Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for VANI in comparison with other companies in the Biotechnology industry. Currently, VANI has a P/B value of 4.8. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with VANI

Add Vivani Medical Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with VANI